Fantastic news.
Trial has finished ahead of time which is virtually unheard of in biotech.
Mid August results due.
I have been invested since IPO and it has gone from studies to Phase 1 to Phase 2 in 3 years. Plenty of other drug bios would still be on Phase 1. Tremendous work by Liz and the team.
Ann: Last Patient Dosed in Phase 2 Stroke Trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.35M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.0¢ | $61.92K | 90.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15912 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 14.24pm 31/07/2025 (20 minute delay) ? |
| AGN (ASX) Chart |